In the world of rare diseases, finding the right diagnosis can be a harrowing and drawn-out journey. Patients often endure multiple misdiagnoses and seek opinions from numerous healthcare professionals before […]
About Ruth O'Keefe
ThinkGenetic to Attend ACMG/SIMD Joint Meeting
ThinkGenetic announces its participation at the 2023 ACMG Annual Clinical Genetics Meeting which is being held in conjunction with the Society for Inherited Metabolic Disorders Meeting for the first time in Salt Lake City, Utah, this March.
ThinkGenetic Announces Participation at 19th Annual WORLDSymposium™ 2023
ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited.
[Press Release] ThinkGenetic Announces Cian Robinson as Chief Revenue Officer to Focus on Growth and Partnership Opportunities
ThinkGenetic, Inc. (thinkgenetic.com) today announces the onboarding of entrepreneurial leader, Cian Robinson, MS, EdD-ABD as Chief Revenue Officer. Mr. Robinson is responsible for collaborating with potential ThinkGenetic clients to uncover opportunities for growth and partnership within ThinkGenetic.
[Audio Interview] ThinkGenetic Leadership Team Interview with RV Radio Part 2
In this second part, RV Radio continues the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day business and finding investment funding.
[Audio Interview] ThinkGenetic Leadership Team Interview with RV Radio Part 1
The ThinkGenetic leadership team was recently interviewed for the RV Radio podcast with Cian Robinson, discussing the origin of ThinkGenetic while giving insight into what it’s like to be diagnosed with a genetic condition later in life when doctors are stumped and existing tools to diagnose are limited.
[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
New Research to be Presented at AAAAI 2022 on Hereditary Angioedema
ThinkGenetic is proud to announce a recent collaborative research project will be presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting this February 25-29th in […]
Introducing Jennifer Dykeman – ThinkGenetic’s 2021 Intern Class
ThinkGenetic is honored to work with incredible interns eager to help ThinkGenetic achieve its mission of reaching and empowering those living with and at risk for genetic conditions. With each […]
